Studied: Cardiovascular and immune diseases; Ph.D.
Experience: Ph.D. and Xendo (since January 2018)
Goals: Growth and contribute beyond
I’m Nadia Vazirpanah and I joined Xendo’s Young Talent program (Medical devices) in January 2018. I was born and partly raised in Iran but it is in the Netherlands that I completed my bachelor study at the Medical Laboratory Research in Groningen and my two Masters at the Vrije University in Amsterdam. During my Ph.D. position at the UMC Utrecht, I had the privilege to collaborate with multiple national and international experts. Simultaneously while working for Xendo, I am completing my dissertation to defend my thesis by November this year.
How do you get ready to start your day?
I live in Utrecht and travel daily to Leiden and use this time to prime my mind and plan strategies on how to tackle daily challenges prior to getting started in the office. However, once I reach Xendo - I first grab a cup of coffee!
What is something you look forward to every day?
Since I plan my day ahead, I am quite prepared for the things that I aim to accomplish throughout the day, hence, what really excites me are opportunities and unplanned events that just happen spontaneously!
Can you name some typical activities?
Selecting and applying appropriate sections of the Medical Device Regulation and standards and customize it specifically for the Medical Device in question. Also, defining and describing a product as adequate as possible is one of the essential activities.
Tell about your colleagues a bit perhaps.
Within Xendo, there are a variety of consultants with diverse ethnical and education background and expertise. Whenever there is a specific question, there is always a colleague willing to communicate and convey his/her knowledge and experiences with a cup of coffee or during lunch.
What is something you do every day?
The most amazing part of being a consultant is the variety of projects and challenges that you face. The rules are always the same, but the game changes continuously! And one thing we implement in all projects is to think and act along with clients.
What is the most challenging part of your job or day?
You have to imagine and picture a device in your mind completely in order not to leave any part undescribed and unaddressed; so you need a vivid imagination.
What makes you happy during your day?
I feed the monkey of my mind by having debates and discussions with my senior colleagues. This way I try to be challenged to think differently and see opportunities from multiple angles and to try and translate them into tailored solutions for each project.
Why did you pick this job?
After finishing my Ph.D., I realized that I enjoy change, different ways of thinking, and delineating a subject over a longer period. Besides this, the contact with a large network of colleagues and clients makes each day of working-life unique and extraordinary.
How does it fit into your career plan?
I learn something by being present in this environment where you’re involved in multiple projects every day. Like Benjamin Franklin said; “Tell me and I forget, Teach me and I remember, Involve me and I learn.” This is how Xendo structures the Young Talent Program.
How does this company define your success?
Parallel to ‘learning on the job’ the success is achieved as a result of preparation, hard work and learning from failure.
To whom would you recommend this line of work?
If you need variety, want to be challenged, think outside of the box, work in a team, and contribute by taking responsibility in projects then you should consider this line of work. Are you gifted with a healthy and bright imagination and do you enjoy divergent projects? Consider working in this line of work within the wonderful world of Medical Devices.
Date: 26.09.2018 | 8:00 - 16:15
Venue: Strelitzer Straße 60, 10115 Berlin at CQ Beratung + Bildung
Costs/fee: Regular - 90,- € | Early-Bird - 75,- € if you register by July
It is an exciting time for companies developing new and complex biopharmaceuticals. As we gain more experience in the application of highly advanced technologies, as well as in new production processes for biopharmaceuticals, the regulatory landscape and recent strategies for the development of these products are rapidly evolving. It is not an easy task to keep track of best development practices and regulatory requirements.
This interactive workshop will support you in your efforts to better understand these relevant topics based on the vast experience of our speakers who will present case studies in their respective fields. As a highlight of this workshop, a panel discussion will take place to address and discuss questions and issues that you are facing in your daily business.
Outcomes of this workshop: gaining insights into improving your product development regarding timelines, costs and risk management.
Who should attend: Professionals and Managers in regulatory and development functions and Financial Investors.
Presentations will be in English, the detailed agenda can be found here.
Our presenters are recommending 3 blogs for pre-reading:
Simulated moving bed (SMB) chromatography technology is a continuous mode of adsorption with enhanced separation efficiency and productivity. The countercurrent effect of this technology also results in improved purity, reduced resin, and buffer requirement. Currently, as a part of the EU subsidized Horizon 2020 project PRODIAS, Xendo gained extensive knowledge of applications and innovation of SMB technology in both packed bed and expanded bed adsorption (EBA) modes
As a technology developer, we share the vision to not only address new challenges but also to create a platform to share knowledge that can trigger both the industrial and academic world towards practical, efficient and sustainable process solutions. Through this symposium, we would like to bring together experts from different sectors to communicate state of the art knowledge on adsorption based technologies like EBA and SMB. After the talks, we aim to conclude the symposium with a priority list of opportunities to drive future implementations and innovations.
The talks are driven by following key attributes while focused on EBA and/or SMB technologies:
Approved delegates will be provided with registration details for the symposium and enjoy a complimentary networking dinner and full accommodation.
27th June 2018, Castle Oud Poelgeest, Oegstgeest (close to Leiden), The Netherlands
Like last year, we will also be
Innovation for Health is the premier event on healthcare innovations in the Netherlands. It provides a unique opportunity to meet leading innovators, to catch up on the latest trends, to present cutting-edge innovations and to engage leaders and
More info: https://www.innovationforhealth.nl/
Rembrandt and van Gogh, tulips, clogs and windmills, a sample of what we’re famous for. We might be small, but we’re a great country. And it’s our pleasure to welcome the European Medicines Agency to The Netherlands.
The Netherlands will prove itself to be a true home to the internationally oriented EMA community and its staff thanks to its excellent accessibility, high-quality of living, and a population consisting of over 180 nationalities.
As a fast-growing company, we are ready to support all life sciences companies during the transition of the EMA from London to Amsterdam. With over 240 efficiently cooperating consultants (including QPs, QPPVs, and Auditors) in different fields of expertise, we’re able to offer our customers a complete palette of services. Especially our familiarity with The Netherlands’ Health Authority, the MEB-CBG, will prove to be an asset for all companies that require expertise regarding their upcoming Regulatory Affairs changes that this transition will bring about.
Please contact us to find out more.
Xendo was named an FD Gazelle 2017 again, meaning we belong to the fastest growing companies in the Netherlands for the third time in a row. The Gazelle Awards, an initiative of the ‘Financieele Dagblad’ (Dutch Financial Times), are awarded annually to the fastest growing enterprises, where the main criterion is a turnover growth of at least 20% per year during a three-year period.
André van de Sande (CEO, Xendo) says:
Our clients increasingly know how to find us for our expertise and support in all phases of product development and we are very grateful for the trust they place in Xendo.
Based on this trust, we have been able to grow our organization from 60 to over 240 employees. We plan to further expand in the Netherlands as well as internationally and as such we are always open to getting into contact with new potential colleagues. Please visit our website to see an overview of our most recent vacancies.
Bringing new products to the market while managing all pharmacovigilance (PV) requirements within a reasonable timeframe can be challenging, especially now that the technical requirements of a PV system are becoming increasingly complex. Getting it right the first time will help you off to a good start.
This is exactly what we can provide you with regarding the necessary support. Our PV experts provide cost-effective solutions in compliance with all regulatory requirements while you focus on what matters to you: the quality and safety of your product.
To assist in achieving a fit-for-purpose PV system and to safeguard your responsibilities as a Marketing Authorisation Holder, we offer an end-to-end solution for small and medium-sized companies who are about to bring a product to the market in the EU and need a fully functional pharmacovigilance system. We can provide the planning, implementation, and maintenance of any or all of the essential parts of your PV system. The complete set-up of your global PV system can be
Our dedicated case processing team makes use of the industry acclaimed standard Oracle Argus Safety Database for Adverse Event Management; including Safety Database Hosting & PV Query Tool. By applying a multi-tenant approach and lean processes with a focus on first-time-right we’re able to offer this software as part of a cost-effective solution. And with this state-of-the-art database, line listings and reports for case processing can be generated independently of the size of a corporation.
Have a look at the schematic overview.
After setting up your basic PV system, we are also fully equipped to provide you with all other PV services like:
So why Xendo? Taking your product to the market requires experience and solutions beyond pharmacovigilance. This is why we aim to offer a complete spectrum, including all the expertise you’ll need to be successful.
Introducing our palette of services that
With many, effectively cooperating consultants in different fields of expertise at your disposal, we’re able to offer you a complete package and peace of mind.
Please contact us to find out more!
Xendo CEO André van de Sande and Xenia Freifrau-von Maltzan brought one of our customized VANMOOF bikes to this years' BIO Europe in Berlin. Several hundred participants showed that the raffle we
Xendo CEO André van de Sande was the keynote speaker at a seminar in Japan about the possibilities that the Dutch Life Sciences industry offers. This event was organized by the Dutch embassy prior to the BIO Japan expo where Xendo participated to increase our exposure as a leading consultant for Japanese companies looking to enter the EU market.
If you are interested then please check out our Japanese service pages:
|Pharmacovigilance||Regulatory Affairs||Quality Management & Lean Six Sigma|
|ファーマコビジランス||規制関連業務||品質管理 & リーンシックス・シグマ|
１０月１０日、パシフィコ横浜で開催される Bio Japan 2017 を前に、大使館にてオランダ・ライフサイエンス・セミナーが開催されました。オランダはレンブラントの時代から医薬学でのイノベーションを担っています。
NL Life Science Seminar was held prior to #biojapanexpo. NL has been the forerunner of life/medical technology since the times of Rembrandt.
You have been redirected.
In 2013, Vigilex has merged with Xendo. In addition to the full spectrum of pharmacovigilance services, together we offer a broader palette of services and are able to take on larger projects in the Life Sciences industry.